It has been reported that pain relief for patients with cancer is suboptimal in Japan. This has been mainly attributed to inadequate dissemination of the World Health Organization (WHO) guidelines for cancer pain management. To better understand this problem, we reviewed how 6 hospital palliative care teams (HPCTs) used the WHO guidelines for unrelieved pain in a 1-year audit that included 534 patients. The HPCT interventions were classified according to the contents of the WHO guidelines. In our study, HPCT interventions involved opioid prescriptions in >80% of referred patients, and “For the Individual” and “Attention to Detail” were the 2 most important principles. Our study indicates which parts of the WHO guidelines should be most heavily emphasized, when disseminating them in Japan.
ChernyNIBaselgaJde ConnoFRadbruchL. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative. Ann Oncol. 2010;21(3):615–626.
2.
GrondSZechDSchugSALynchJLehmannKA. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage. 1991;6(7):411–422.
VentafriddaVTamburiniMCaraceniADe ConnoFNaldiF. A validation study of the WHO method for cancer pain relief. Cancer. 1987;59(4):850–856.
5.
ZechDFGrondSLynchJHertelDLehmannKA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63(1):65–76.
6.
Ministry of Health, Labour, and Welfare (MHLW). Report of research and investigative commission about end-of-life care[In Japanese]. Web site. http://www.mhlw.go.jp/shingi/2004/07/s0723-8d9.html. Published July 16, 2004. Accessed September 20, 2015.
7.
MoritaTFujimotoKTeiY. Palliative care team: the first year audit in Japan. J Pain Symptom Manage. 2005;29(5):458–465.
8.
FoleyKM. How well is cancer pain treated?Palliat Med. 2011;25(5):398–401.
9.
HigashiTYoshimotoTMatobaM. Prevalence of analgesic prescriptions among patients with cancer in Japan: an analysis of health insurance claims data. Glob J Health Sci. 2012;4(6):197–203.
10.
World Health Organization. Cancer Pain Relief. Geneva: WHO; 1986.
11.
TwycrossRG. Pain Relief in Advanced Cancer. Edinburgh: Churchill Livingstone; 1994.
HanksGChernyNIChristakisNA, eds. Oxford Textbook of Palliative Medicine. 4th ed. Oxford: Oxford University Press; 2009.
14.
Japan Clinical Oncology Group. Additional Table of Performance Status[In Japanese]. 1999. Web site. http://www.jcog.jp/doctor/tool/C_150_0050.pdf. Published April 30, 1999. Accessed September 20, 2015.
15.
BlagdenSPCharmanSCSharplesLDMageeLRGilliganD. Performance status score: do patients and their oncologists agree?Br J Cancer. 2003;89(6):1022–1027.
16.
KalsoEVainioA. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther. 1990;47(5):639–646.
17.
MercadanteSFerreraPVillariPCasuccioAIntravaiaGMangioneS. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage. 2009;37(4):632–641.
18.
YoshimotoTHisadaAYomiyaK. Efficacy and safety of compound oxycodone injection for cancer pain relief-a multicenter survey of prescriptions[In Japanese]. Gan To Kagaku Ryoho. 2010;37(5):871–878.
19.
SwarmRAAbernethyAPAnghelescuDL. Adult cancer pain. J Natl Compr Canc Netw. 2010;8(9):1046–1086.
20.
FarrarJTYoungJPJrLaMoreauxLWerthJLPooleRM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149–158.
21.
BrockCOlesenSSOlesenAEFrokjaerJBAndresenTDrewesAM. Opioid-induced bowel dysfunction: pathophysiology and management. Drugs. 2012;72(14):1847–1865.
22.
ClemensKEMikusG. Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain. Expert Opin Pharmacother. 2010;11(2):297–310.
23.
KurzASesslerDI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs. 2003;63(7):649–671.
24.
GrondSZechDLynchJDiefenbachCSchugSALehmannKA. Validation of World Health Organization guidelines for pain relief in head and neck cancer. A prospective study. Ann Otol Rhinol Laryngol. 1993;102(5):342–348.
25.
YamaguchiTNaritaMMoritaTKizawaYMatobaM. Recent developments in the management of cancer pain in Japan: education, clinical guidelines and basic research. Jpn J Clin Oncol. 2012;42(12):1120–1127.
26.
KhanMIWalshDBrito-DellanN. Opioid and adjuvant analgesics: compared and contrasted. Am J Hosp Palliat Care. 2011;28(5):378–383.
27.
LovellMRForderPMStocklerMR. A randomized controlled trial of a standardized educational intervention for patients with cancer pain. J Pain Symptom Manage. 2010;40(1):49–59.
28.
GoldbergRJ. Practical Guide to the Care of the Psychiatric Patient. 2nd ed. St. Louis, MO: Mosby; 1998.
29.
MeierDEBeresfordL. Consultation etiquette challenges palliative care to be on its best behavior. J Palliat Med. 2007;10(1):7–11.
30.
HigginsonIJEvansCJ. What is the evidence that palliative care teams improve outcomes for cancer patients and their families?Cancer J. 2010;16(5):423–435.
31.
IwaseSMurakamiTSaitoYNakagawaK. Preliminary statistical assessment of intervention by a palliative care team working in a Japanese general inpatient unit. Am J Hosp Palliat Care. 2007;24(1):29–35.
32.
Gomez-BatisteXPorta-SalesJEspinosa-RojasJPascual-LopezATucaARodriguezJ. Effectiveness of palliative care services in symptom control of patients with advanced terminal cancer: a spanish, multicenter, prospective, quasi-experimental, pre-post study. J Pain Symptom Manage. 2010;40(5):652–660.
33.
AkashiMYanoEArugaE. Under-diagnosis of pain by primary physicians and late referral to a palliative care team. BMC Palliat Care. 2012;11:7.
34.
MeuserTPietruckCRadbruchLStutePLehmannKAGrondS. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001;93(3):247–257.
35.
RustoenTMoumTPadillaGPaulSMiaskowskiC. Predictors of quality of life in oncology outpatients with pain from bone metastasis. J Pain Symptom Manage. 2005;30(3):234–242.
36.
TamiyaNOkunoMKashiwakgiMNishikitaniMArugaE. Collaboration between physicians and a hospital-based palliative care team in a general acute-care hospital in Japan. BMC Palliat Care. 2010;9:13.
37.
MelottiRMSamolsky-DekelBGRicchiE. Pain prevalence and predictors among inpatients in a major Italian teaching hospital. A baseline survey towards a pain free hospital. Eur J Pain. 2005;9(5):485–495.
